Drug · DIN 02429802
LORAZEPAM
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 3, 2018.
- Drug Identification Number (DIN)
- 02429802
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Targeted substances (cdsa iv)
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Lorazepam N05BA06
- Class
- Human
- Record last updated
- June 23, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LORAZEPAM | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 28, 2014: NOC 16010New Drug Submission (NDS) · Licensing agreement between two companies
Other DINs named LORAZEPAM
- DIN 02351072 · Cancelled Post Market
- DIN 02351080 · Cancelled Post Market
- DIN 02351099 · Cancelled Post Market
- DIN 02429810 · Cancelled Post Market
- DIN 02429829 · Cancelled Post Market